Cargando…
Indomethacin Disrupts the Formation of β-Amyloid Plaques via an α2-Macroglobulin-Activating lrp1-Dependent Mechanism
Epidemiological studies have implied that the nonsteroidal anti-inflammatory drug (NSAID) indomethacin slows the development and progression of Alzheimer’s disease (AD). However, the underlying mechanisms are notably understudied. Using a chimeric mouse/human amyloid precursor protein (Mo/HuAPP695sw...
Autores principales: | Guan, Pei-Pei, Yang, Liu-Qing, Xu, Guo-Biao, Wang, Pu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348656/ https://www.ncbi.nlm.nih.gov/pubmed/34360951 http://dx.doi.org/10.3390/ijms22158185 |
Ejemplares similares
-
alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)- dependent internalization of the urokinase receptor
Publicado: (1995) -
Microglial responses to amyloid β peptide opsonization and indomethacin treatment
por: Strohmeyer, Ronald, et al.
Publicado: (2005) -
Apolipoprotein E-Containing Lipoproteins and LRP1 Protect From NMDA-Induced Excitotoxicity Associated With Reducing α2-Macroglobulin in Müller Glia
por: Hayashi, Hideki, et al.
Publicado: (2021) -
Activated α(2)-Macroglobulin Regulates LRP1 Levels at the Plasma Membrane through the Activation of a Rab10-dependent Exocytic Pathway in Retinal Müller Glial Cells
por: Jaldín-Fincati, Javier R., et al.
Publicado: (2019) -
Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms
por: Wyatt, Amy R., et al.
Publicado: (2013)